BioDrone Therapeutics Inc.
BioDrone Therapeutics Inc.
  • Home
  • BioDrone Platform
  • News
  • Contact

Biodrone News

Reyon and MDimune Sign CDVs-Mediated mRNA Delivery Partnership

May 13, 2021  Reyon and MDimune has announced the signing of a partnership focused on mRNA delivery for antivirus vaccine and rare genetic disorder.  

Find out more

Research Collaboration with Navigo Proteins on Affilin®-Mediated Targeting of EVs

May 11, 2021   Navigo Proteins and MDimune announced a technology collaboration to achieve tissue-targeting of extracellular vesicles (EVs), Affilin®-mediated delivery of CDVs specifically to solid tumor targets. 

Find out more

Partnership with Evercyte for developing tumor-targeting EVs

Apr 5, 2021 MDimune and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining their technologies. 

Find out more

Service Agreement with ExoNanoRNA to Advance Targeted Drug Delivery for Cancer

Mar 15, 2021 ExonanoRNA and MDimune have entered into a service agreement to develop targeted siRNA therapy in oncology applications. 

Find out more

Korean Researchers Received MDimune’s 1st BioDrone® Award

Oct 30, 2020 MDimune announced the signing of research agreements with Pohang University of Science and Technology (POSTECH), Konkuk University, and Catholic University. 

Find out more

MDimune Selected by Lonza to the Startup Creasphere Program

Oct 28, 2020 Plug and Play, headquartered in Silicon Valley, California, announced that MDimune will be partnering with Lonza.  MDimune is among 11 Batch 5 startups to join the global startup incubation program ‘Startup Creasphere’.   

Find out more

Received “Best Cell Therapy Technology of the Year” award

Oct 26, 2020 BioDrone® platform technology was awarded the “Best Cell Therapy Technology of the Year” at the annual Cell Therapy World Asia 2020 conference. 

Find out more

Collaboration with EV Experts at PMU

Apr 30, 2020 MDimune Signed a Research Collaboration Agreement with Paracelsus Medical University for EV Therapeutics Development.

Find out more

U.S. Patent Acquired

Apr 8, 2020 MDimune Received U.S. Patent on BioDrone® Technology.

Find out more

Copyright © 2021 BioDrone Therapeutics Inc. - All Rights Reserved.